Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study

被引：0

作者：

Taylor, Peter C. ^{[1
]}

Keystone, Edward C. ^{[2
,3
]}

van der Heijde, D. ^{[4
]}

Tanaka, Yoshiya ^{[5
]}

Ishii, Taeko ^{[6
]}

Emoto, Kahaku ^{[6
]}

Yang, Lili ^{[6
]}

Arora, Vipin ^{[6
]}

Gaich, Carol L. ^{[6
]}

Rooney, Terence ^{[6
]}

Schlichting, Douglas E. ^{[6
]}

Macias, William ^{[6
]}

de Bono, Stephanie ^{[6
]}

Weinblatt, Michael E. ^{[7
]}

机构：

[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Sci, Kennedy Inst Rheumatol, Oxford, England

[2] Univ Toronto, Toronto, ON, Canada

[3] Univ Toronto, Mt Sinai Hosp, Rebecca MacDonald Ctr, Toronto, ON M5G 1X5, Canada

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Japan

[6] Eli Lilly & Co, Indianapolis, IN 46285 USA

[7] Brigham & Womens Hosp, Boston, MA 02115 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] Baricitinib versus placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy: Results of a phase 3 study
Taylor, P. C.
Keystone, E. C.
van der Heijde, D.
Tanaka, Y.
Ishii, T.
Emoto, K.
Yang, L.
Arora, V
Gaich, C.
Rooney, T.
Schlichting, D.
Macias, W. L.
de Bono, S.
Weinblatt, M. E.
[J]. SWISS MEDICAL WEEKLY, 2016, 146 : 9S - 9S
[2] Baricitinib vs. placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy: results of a phase 3 study
Taylor, P.
Keystone, E. C.
van der Heijde, D.
Tanaka, Y.
Ishii, T.
Emoto, K.
Yang, L.
Arora, V.
Gaich, C.
Rooney, T.
Schlichting, D.
Macias, W. L.
De Bono, S.
Weinblatt, M. E.
Larsson, E.
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 8 - 8
[3] PATIENT-REPORTED OUTCOMES FROM A PHASE 3 STUDY OF BARICITINIB VERSUS PLACEBO OR ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO BACKGROUND METHOTREXATE THERAPY
Keystone, E.
Taylor, P.
Tanaka, Y.
Gaich, C.
DeLozier, A. M.
Dudek, A.
Zamora, J. Velasco
Cobos, J. Covarrubias
De Bono, S.
Arora, V.
Yang, L.
Linetzky, B.
Weinblatt, M. E.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 412 - 413
[4] Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study
Li, Z.
Hu, J.
Bao, C.
Li, X.
Li, X.
Xu, J.
Spindler, A. J.
Zhang, X.
Xu, J.
He, D.
Li, Z.
Wang, G.
Yang, Y.
Wu, H.
Ji, F.
Tao, H.
Zhan, L.
Bai, F.
Rooney, T. P.
Zerbini, C. A. F.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : 732 - 741
[5] EFFICACY AND SAFETY OF BARICITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: SUMMARY RESULTS FROM THE 52-WEEK PHASE 3 RA-BEAM STUDY
Taylor, Peter C.
Krogulec, Marek
Dudek, Anna
Dudler, Jean
Drescher, Edit
Cseuz, Regina
Kausiene, Rasa
Andersone, Daina
Unikiene, Dalia
Sanchez Burson, Juan
Blanco Alonso, Ricardo
Dvorak, Zdenek
Ghizdavescu, Andrei
Irto, Ildiko
Larsson, Esbjorn
Bello, Natalia
Barry, Jane
Durand, Frederick
Holzkaemper, Thorsten
Otawa, Susan
de Bono, Stephanie
Keystone, Edward C.
Rubbert-Roth, Andrea
Combe, Bernard
De La Torre, Inmaculada
[J]. RHEUMATOLOGY, 2017, 56 : 26 - 27
[6] A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate
Fleischmann, Roy
Pangan, Aileen L.
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, Andrew
Li, Yihan
Zhou, Yijie
Othman, Ahmed A.
Song, In-Ho
Genovese, Mark C.
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[7] Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
Combe, Bernard
Kivitz, Alan
Tanaka, Yoshiya
van der Heijde, Desiree
Simon, J. Abraham
Baraf, Herbert S. B.
Kumar, Uma
Matzkies, Franziska
Bartok, Beatrix
Ye, Lei
Guo, Ying
Tasset, Chantal
Sundy, John S.
Jahreis, Angelika
Genovese, Mark C.
Mozaffarian, Neelufar
Landewe, Robert B. M.
Bae, Sang-Cheol
Keystone, Edward C.
Nash, Peter
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 848 - 858
[8] Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study
Yang, Yue
Xu, Jianhua
Xu, Jian
Li, Xingfu
Hu, Jiankang
Li, Xiangpei
Zhang, Xiao
He, Dongyi
Bao, Chunde
Li, Zhijun
Wang, Guochun
Zerbini, Cristiano A. F.
Spindler, Alberto J.
Kannowski, Carol L.
Wu, Hanjun
Ji, Fei
Zhan, Lujing
Liu, Mengru
Li, Zhanguo
[J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
[9] Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Results of a Phase III Study
Genovese, Mark C.
Fleischmann, Roy
Kivitz, Alan J.
Rell-Bakalarska, Maria
Martincova, Renata
Fiore, Stefano
Rohane, Patricia
van Hoogstraten, Hubert
Garg, Anju
Fan, Chunpeng
van Adelsberg, Janet
Weinstein, Steven P.
Graham, Neil M. H.
Stahl, Neil
Yancopoulos, George D.
Huizinga, Tom W. J.
van der Heijde, Desiree
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (06) : 1424 - 1437
[10] Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial
Fleischmann, Roy
Pangan, Aileen L.
Song, In-Ho
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, AndrewJ
Li, Yihan
Zhou, Yijie
Othman, Ahmed A.
Genovese, Mark C.
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1788 - 1800

← 1 2 3 4 5 →